These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1236886)

  • 1. [First trials with the cockscomb candidiasis test as an in vitro screening model for antifungal agents].
    Kramer A; Krause R; Weuffen W; Rödel B
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):259-62. PubMed ID: 1236886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testing of antimycotic active substances on the model of experimental cockscomb epidermophytosis. I. Methods and testing of 3,5-dibenzyl-2-thion-tetrahydro-1,3,5-thiadiazine (D 47)].
    Weuffen W
    Mykosen; 1968 Jan; 11(1):33-9. PubMed ID: 5758230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental cockscomb candidiasis as a model for testing antifungal agents effective against blastomyces].
    Kramer A; Rödel R; Krause R; Weuffen W; Kühne R
    Z Gesamte Hyg; 1974; 20(8):509-12. PubMed ID: 4462317
    [No Abstract]   [Full Text] [Related]  

  • 4. [Model of experimental Candida mycosis for testing fungistatics].
    Kulikova VN; Minasian MA; Razbitskaia GT
    Veterinariia; 1979 Jan; (1):47-8. PubMed ID: 419668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testing of antimycoticly active substances on the model of experimental cockscomb epidermophytosis. 2. Comparison of results of fungistasis, fungicidity and cockscomb epidermophytosis tests].
    Weuffen W; Kramer A
    Mykosen; 1970 Jan; 13(1):39-44. PubMed ID: 5480482
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Candida infected hen's egg. An alternative test system for systemic anticandida activity].
    Härtl A; Hillesheim HG; Künkel W; Schrinner EJ
    Arzneimittelforschung; 1995 Aug; 45(8):926-8. PubMed ID: 7575763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antifungal agents in the cornea. I. A comparative study.
    O'Day DM; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1098-102. PubMed ID: 6874272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testing of antimycoticly active substances on the model of experimental cockscomb dermatophytosis. 3. Comparative histological studies of mycosis foci of the cockscomb and of the back skin of the guinea pig].
    Sulzmann R; Weuffen W; Kramer A
    Mykosen; 1971 Jan; 14(1):15-8. PubMed ID: 4924704
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo models: evaluating antifungal agents.
    Dixon DM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):729-38. PubMed ID: 3448452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapy.
    Andes D
    Methods Mol Med; 2005; 118():111-28. PubMed ID: 15888938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal properties of 1,2-dihydro-3-methylpyrido-(3,2-e)-as-triazine dihydrochloride (I-476).
    Wieczorek J; Mordarski M; Rykowski A; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):339-44. PubMed ID: 3909989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.
    Hope WW; Drusano GL
    Clin Microbiol Infect; 2009 Jul; 15(7):602-12. PubMed ID: 19673971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological findings in the cock's womb experimentally infected with Candida albicans].
    Krause R; Kramer A
    Dermatol Monatsschr; 1976 Feb; 162(2):186-7. PubMed ID: 955199
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of mycoses in otorhinolaryngology].
    Constantinescu F; Midan F
    Otorinolaringologie; 1972; 17(3):211-6. PubMed ID: 5030472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapeutic properties of sanquiritrin in treatment of experimental candidiasis].
    Vichkanova SA; Adgina VV
    Antibiotiki; 1973 Oct; 18(10):902-5. PubMed ID: 4762740
    [No Abstract]   [Full Text] [Related]  

  • 17. Fingolimod. Mitsubishi Pharma/Novartis.
    Dumont FJ
    IDrugs; 2005 Mar; 8(3):236-53. PubMed ID: 15772896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of vaginal trichomoniasis and candidiasis in mice].
    Wildfeuer A
    Arzneimittelforschung; 1974 Jun; 24(6):937-43. PubMed ID: 4603387
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination antifungals: an update.
    Segal BH; Steinbach WJ
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal properties of a novel 1,2,4-triazine derivative I 319.
    Wieczorek J; Mordarski M; Rykowski A; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):727-33. PubMed ID: 7212980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.